Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M343Revenue (TTM) $M25.3Net Margin (%)-261.8Altman Z-Score6.9
Enterprise Value $M171EPS (TTM) $-0.9Operating Margin %-283.7Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.8Pre-tax Margin (%)-281.5Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %-1.8Quick Ratio12.2Cash flow > EarningsY
Price/Sales13.45-y EBITDA Growth Rate %-1.6Current Ratio12.2Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-31.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-35.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M70.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SGMO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SGMOFirst Eagle Investment 2016-06-30 Reduce-0.01%$5.14 - $7.5
($6.37)
$ 4.86-24%Reduce -84.20%60,000
SGMOFirst Eagle Investment 2016-03-31 Add$4.91 - $9.13
($6.04)
$ 4.86-20%Add 89.86%379,727
SGMOJoel Greenblatt 2015-09-30 Sold Out $5.64 - $10.86
($8.27)
$ 4.86-41%Sold Out0
SGMOFirst Eagle Investment 2015-09-30 Buy $5.64 - $10.86
($8.27)
$ 4.86-41%New holding200,000
SGMOFirst Eagle Investment 2015-06-30 Sold Out -0.02%$10.35 - $15.68
($12.96)
$ 4.86-63%Sold Out0
SGMOJoel Greenblatt 2015-06-30 Buy $10.35 - $15.68
($12.94)
$ 4.86-62%New holding30,334
SGMOJoel Greenblatt 2015-03-31 Sold Out -0.0021%$12.64 - $18.54
($15.47)
$ 4.86-69%Sold Out0
SGMOJoel Greenblatt 2014-12-31 Buy $9.85 - $16.53
($12.15)
$ 4.86-60%New holding17,441
SGMOFirst Eagle Investment 2014-06-30 Add0.01%$11.71 - $17.95
($14.37)
$ 4.86-66%Add 34.10%536,380
SGMOFirst Eagle Investment 2014-03-31 Reduce-0.02%$13.25 - $23.86
($19.12)
$ 4.86-75%Reduce -52.81%400,000
SGMOFirst Eagle Investment 2013-09-30 Add0.01%$7.92 - $11.28
($9.95)
$ 4.86-51%Add 99.73%847,550
SGMOFirst Eagle Investment 2013-06-30 Add$7.31 - $10.65
($8.72)
$ 4.86-44%Add 41.45%424,350
SGMOFirst Eagle Investment 2013-03-31 Buy 0.01%$6.01 - $10.8
($8.89)
$ 4.86-45%New holding300,000
SGMOFirst Eagle Investment 2010-03-31 Sold Out $4.76 - $6.63
($5.63)
$ 4.86-14%Sold Out0
SGMOFirst Eagle Investment 2009-12-31 Buy $5.04 - $8.09
($5.87)
$ 4.86-17%New holding470
SGMOFirst Eagle Investment 2009-09-30 Sold Out -0.01%$4.26 - $9.03
($6.39)
$ 4.86-24%Sold Out0
SGMOFirst Eagle Investment 2009-06-30 Buy 0.01%$3.51 - $4.98
($4.2)
$ 4.8616%New holding260,600
SGMOFirst Eagle Investment 2009-03-31 Sold Out -0.01%$2.99 - $5.05
($4.1)
$ 4.8619%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SGMO is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SGMO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANPHIER EDWARD O IIPresident & CEO 2015-07-15Sell25,000$10.43-53.4view
Wolff Henry WardExec VP & CFO 2015-07-13Sell12,000$10-51.4view
LANPHIER EDWARD O IIPresident & CEO 2015-06-15Sell25,000$11.08-56.14view
Wolff Henry WardExec VP & CFO 2015-06-10Sell12,000$12.21-60.2view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-06-05Sell15,000$12.29-60.46view
RINGO WILLIAM RDirector 2015-06-03Sell2,200$12.44-60.93view
Gregory Philip DSVP of Research & CSO 2015-06-01Sell15,000$12.39-60.77view
LANPHIER EDWARD O IIPresident & CEO 2015-05-15Sell25,000$11.51-57.78view
Wolff Henry WardExec VP & CFO 2015-05-11Sell12,000$13.25-63.32view
ANDO DALE GVP, Therapeutic Dev. & CMO 2015-05-05Sell15,000$12.29-60.46view

Quarterly/Annual Reports about SGMO:

News about SGMO:

Articles On GuruFocus.com
Biogen or Bluebird: Which Will Lead in SCD? Apr 30 2015 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 03 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2010 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Nov 06 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) Aug 03 2009 
Sangamo BioSciences Inc. Reports Operating Results (10-Q) May 05 2009 

More From Other Websites
Sangamo BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : SGMO-US :... Sep 26 2016
ETF’s with exposure to Sangamo BioSciences, Inc. : September 21, 2016 Sep 21 2016
Sangamo BioSciences Receives Orphan Drug Designation From The FDA For SB-FIX, The First Application... Sep 06 2016
Sangamo BioSciences Receives Orphan Drug Designation From The FDA For SB-FIX, The First Application... Sep 06 2016
Sangamo BioSciences Announces Participation At Upcoming Investor Conferences Aug 31 2016
Sangamo BioSciences Announces Participation At Upcoming Investor Conferences Aug 31 2016
ETF’s with exposure to Sangamo BioSciences, Inc. : August 19, 2016 Aug 19 2016
SANGAMO BIOSCIENCES INC Financials Aug 13 2016
Sangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016 Aug 11 2016
Sangamo BioSciences Announces Presentation At The 2016 Wedbush PacGrow Healthcare Conference Aug 09 2016
ETF’s with exposure to Sangamo BioSciences, Inc. : August 8, 2016 Aug 08 2016
Sangamo BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : SGMO-US : August... Aug 05 2016
SANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report Aug 04 2016
Earnings Wrap: Transocean (RIG), XPO Logistics (XPO), Exelixis (EXEL), 2 More Aug 04 2016
Edited Transcript of SGMO earnings conference call or presentation 3-Aug-16 9:00pm GMT Aug 03 2016
Sangamo reports 2Q loss Aug 03 2016
Sangamo reports 2Q loss Aug 03 2016
SANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 03 2016
Sangamo BioSciences Reports Second Quarter 2016 Financial Results Aug 03 2016
Sangamo BioSciences Reports Second Quarter 2016 Financial Results Aug 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)